Claris gets nod to market 2 anti-infectives in Russia

27 May 2011 Evaluate
Claris Lifesciences has received approval from the Ministry of Health to market two more anti-infectives, namely Fluconazole IV 100 ml. and Levofloxacin IV 100 ml.Fluconazole is a triazole antifungal drug used in the treatment and prevention of superficial and systemic fungal infections, whereas Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class that is used to treat a broad range of infections. Claris now has another four in the pipeline for registration in Russia.
crackcrack
Peers
Company Name CMP
Redington 216.95
Adani Enterprises 3263.50
Amrapali Industries 15.35
Rashi Peripheral 341.75
Compuage Infocom 3.71
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.